[HTML][HTML] Haemodynamic Effects of Sacubitril/Valsartan Initiation in Outpatients with Chronic Heart Failure
H Fröhlich, N Frey, B Estler, M Mäck, P Schlegel… - American Journal of …, 2022 - Springer
Abstract Background Sacubitril/valsartan (S/V) improves outcomes in patients with heart
failure with reduced ejection fraction (HFrEF). Data about the immediate, short-, and …
failure with reduced ejection fraction (HFrEF). Data about the immediate, short-, and …
Haemodynamic Effects of Sacubitril/Valsartan Initiation in Outpatients with Chronic Heart Failure.
H Fröhlich, N Frey, B Estler, M Mäck… - American Journal of …, 2022 - europepmc.org
Background Sacubitril/valsartan (S/V) improves outcomes in patients with heart failure with
reduced ejection fraction (HFrEF). Data about the immediate, short-, and intermediate-term …
reduced ejection fraction (HFrEF). Data about the immediate, short-, and intermediate-term …
[HTML][HTML] Haemodynamic Effects of Sacubitril/Valsartan Initiation in Outpatients with Chronic Heart Failure
H Fröhlich, N Frey, B Estler, M Mäck… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Background Sacubitril/valsartan (S/V) improves outcomes in patients with heart failure with
reduced ejection fraction (HFrEF). Data about the immediate, short-, and intermediate-term …
reduced ejection fraction (HFrEF). Data about the immediate, short-, and intermediate-term …
Haemodynamic Effects of Sacubitril/Valsartan Initiation in Outpatients with Chronic Heart Failure
H Fröhlich, N Frey, B Estler, M Mäck… - … devices, and other …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Sacubitril/valsartan (S/V) improves outcomes in patients with heart failure with
reduced ejection fraction (HFrEF). Data about the immediate, short-, and intermediate-term …
reduced ejection fraction (HFrEF). Data about the immediate, short-, and intermediate-term …
Haemodynamic Effects of Sacubitril/Valsartan Initiation in Outpatients with Chronic Heart Failure.
H Fröhlich, N Frey, B Estler, M Mäck… - American Journal of …, 2022 - europepmc.org
Background Sacubitril/valsartan (S/V) improves outcomes in patients with heart failure with
reduced ejection fraction (HFrEF). Data about the immediate, short-, and intermediate-term …
reduced ejection fraction (HFrEF). Data about the immediate, short-, and intermediate-term …